Most prior attempts to develop mechanism-targeting interventions for APS have entailed the use of proteins or peptides that mimic sequences within β2-GPI or apoER2 implicated in their actions in APS. This evidence concerns the gene LRP8 and autoimmune polyendocrinopathy.